Prescott Group Capital Management, a greater than 10% shareholder of
PharmAthene PIP, urges all stockholders to vote AGAINST
the issuance of shares needed to complete the proposed merger with
Theraclone Sciences, Inc. and AGAINST
giving PharmAthene the right to adjourn the upcoming special meeting.
Prescott notes that Institutional Shareholder Services Inc. (ISS), a
leading provider of corporate governance solutions, also recommends that
PharmAthene stockholders vote AGAINST both
of these key proposals. Additionally, Prescott urges shareholders to
vote AGAINST all five proposals being
submitted to a vote of PharmAthene stockholders at the scheduled
December 3rd special meeting.
Prescott is not soliciting proxies relating to the meeting and
See full press release
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in